Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Day One Biopharmaceuticals (DAWN) Tax Provisions (2024)

Historic Tax Provisions for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Q4 2024 value amounting to $6.4 million.

  • Day One Biopharmaceuticals' Tax Provisions changed N/A to $6.4 million in Q4 2024 from the same period last year, while for Sep 2025 it was $6.4 million, marking a year-over-year increase of 86179.1%. This contributed to the annual value of $7.1 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2024, Day One Biopharmaceuticals' Tax Provisions is $6.4 million.
  • Day One Biopharmaceuticals' 5-year Tax Provisions high stood at $6.4 million for Q4 2024, and its period low was -$882000.0 during Q3 2024.